Integrative Analysis of Somatic Mutations Altering MicroRNA Targeting in Cancer Genomes

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Ziebarth, Jesse D ^a   Bhattacharya, Anindya ^a   Cui, Yan ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 125B;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; BMPR1B GENE; CANCER GENETICS; CELL PROLIFERATION; EPHA3 GENE; GENE DISRUPTION; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE TARGETING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GSDMA GENE; KLK3 GENE; LUNG CANCER; LUNG SMALL CELL CANCER; MELANOMA; MITF GENE; PROSTATE CANCER; SCG3 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; SPRY4 GENE; TAL1 GENE; THERMODYNAMICS; TUMOR GENE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CELL TRANSFORMATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; GERM-LINE MUTATION; HUMANS; LINKAGE DISEQUILIBRIUM; MICRORNAS; MUTATION; MUTATION RATE; NEOPLASM METASTASIS; NEOPLASMS;

EID: 84867612772     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047137     Document Type: Article

References (91)

1. Stratton MR, (2011) Exploring the genomes of cancer cells: progress and promise. Science 331: 1553-1558.
2. Boehm JS, Hahn WC, (2011) Towards systematic functional characterization of cancer genomes. Nat Rev Genet 12: 487-498.
3. Chin L, Gray JW, (2008) Translating insights from the cancer genome into clinical practice. Nature 452: 553-563.
4. Chin L, Andersen JN, Futreal PA, (2011) Cancer genomics: from discovery science to personalized medicine. Nat Med 17: 297-303.
5. Shi Z, Moult J, (2011) Structural and functional impact of cancer-related missense somatic mutations. J Mol Biol 413: 495-512.
6. Reva B, Antipin Y, Sander C, (2011) Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res 39: e118.
7. Chin L, Hahn WC, Getz G, Meyerson M, (2011) Making sense of cancer genomic data. Genes Dev 25: 534-555.
8. Lee W, Jiang Z, Liu J, Haverty PM, Guan Y, et al. (2010) The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465: 473-477.
9. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, et al. (2010) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191-196.
10. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, et al. (2010) A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463: 184-190.
11. Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, et al. (2011) The genomic complexity of primary human prostate cancer. Nature 470: 214-220.
12. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
13. Medina PP, Slack FJ, (2008) microRNAs and cancer: an overview. Cell Cycle 7: 2485-2492.
14. Saunders MA, Liang H, Li WH, (2007) Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A 104: 3300-3305.
15. Sethupathy P, Collins FS, (2008) MicroRNA target site polymorphisms and human disease. Trends Genet 24: 489-497.
16. Bao L, Zhou M, Wu L, Lu L, Goldowitz D, et al. (2007) PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Res 35: D51-54.
17. Chen K, Song F, Calin GA, Wei Q, Hao X, et al. (2008) Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis 29: 1306-1311.
18. Ziebarth JD, Bhattacharya A, Chen A, Cui Y, (2012) PolymiRTS Database 2.0: linking polymorphisms in microRNA target sites with human diseases and complex traits. Nucleic Acids Res 40: D216-221.
19. Ryan BM, Robles AI, Harris CC, (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10: 389-402.
20. Godshalk SE, Paranjape T, Nallur S, Speed W, Chan E, et al. (2011) A Variant in a MicroRNA complementary site in the 3′ UTR of the KIT oncogene increases risk of acral melanoma. Oncogene 30: 1542-1550.
21. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, et al. (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99: 15524-15529.
22. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801.
23. Chen AX, Yu KD, Fan L, Li JY, Yang C, et al. (2011) Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibility. PLoS Genet 7: e1002259.
24. Zhang L, Liu Y, Song F, Zheng H, Hu L, et al. (2011) Functional SNP in the microRNA-367 binding site in the 3′UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification. Proc Natl Acad Sci U S A 108: 13653-13658.
25. Mayr C, Hemann MT, Bartel DP, (2007) Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315: 1576-1579.
26. Thomas LF, Saito T, Saetrom P, (2011) Inferring causative variants in microRNA target sites. Nucleic Acids Res 39: e109.
27. Richardson K, Lai CQ, Parnell LD, Lee YC, Ordovas JM, (2011) A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS. BMC Genomics 12: 504.
28. Ramsingh G, Koboldt DC, Trissal M, Chiappinelli KB, Wylie T, et al. (2010) Complete characterization of the microRNAome in a patient with acute myeloid leukemia. Blood 116: 5316-5326.
29. Hammell M, (2010) Computational methods to identify miRNA targets. Semin Cell Dev Biol 21: 738-744.
30. Saito T, Saetrom P, (2010) MicroRNAs-targeting and target prediction. N Biotechnol 27: 243-249.
31. Garcia DM, Baek D, Shin C, Bell GW, Grimson A, et al. (2011) Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol 18: 1139-1146.
32. Sethupathy P, Megraw M, Hatzigeorgiou AG, (2006) A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods 3: 881-886.
33. Alexiou P, Maragkakis M, Papadopoulos GL, Reczko M, Hatzigeorgiou AG, (2009) Lost in translation: an assessment and perspective for computational microRNA target identification. Bioinformatics 25: 3049-3055.
34. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, et al. (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141: 129-141.
35. Chi SW, Zang JB, Mele A, Darnell RB, (2009) Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460: 479-486.
36. Ellwanger DC, Buttner FA, Mewes HW, Stumpflen V, (2011) The sufficient minimal set of miRNA seed types. Bioinformatics 27: 1346-1350.
37. Kozomara A, Griffiths-Jones S, (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152-157.
38. Ruepp A, Kowarsch A, Schmidl D, Buggenthin F, Brauner B, et al. (2010) PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes. Genome Biol 11: R6.
39. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4: 177-183.
40. Cardoso BA, de Almeida SF, Laranjeira AB, Carmo-Fonseca M, Yunes JA, et al. (2011) TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells. Leukemia 25: 1578-1586.
41. Moss AC, Jacobson GM, Walker LE, Blake NW, Marshall E, et al. (2009) SCG3 transcript in peripheral blood is a prognostic biomarker for REST-deficient small cell lung cancer. Clin Cancer Res 15: 274-283.
42. Saeki N, Usui T, Aoyagi K, Kim DH, Sato M, et al. (2009) Distinctive expression and function of four GSDM family genes (GSDMA-D) in normal and malignant upper gastrointestinal epithelium. Genes Chromosomes Cancer 48: 261-271.
43. Saeki N, Kim DH, Usui T, Aoyagi K, Tatsuta T, et al. (2007) GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling. Oncogene 26: 6488-6498.
44. Fox BP, Tabone CJ, Kandpal RP, (2006) Potential clinical relevance of Eph receptors and ephrin ligands expressed in prostate carcinoma cell lines. Biochem Biophys Res Commun 342: 1263-1272.
45. Bemis LT, Chen R, Amato CM, Classen EH, Robinson SE, et al. (2008) MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res 68: 1362-1368.
46. Saetrom P, Biesinger J, Li SM, Smith D, Thomas LF, et al. (2009) A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res 69: 7459-7465.
47. The 1000 Genomes Project Consortium (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
48. Penney KL, Schumacher FR, Kraft P, Mucci LA, Sesso HD, et al. (2011) Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels. Carcinogenesis 32: 853-859.
49. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, et al. (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40: 316-321.
50. Tsang WP, Ng EK, Ng SS, Jin H, Yu J, et al. (2010) Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 31: 350-358.
51. Tsuchiya S, Fujiwara T, Sato F, Shimada Y, Tanaka E, et al. (2011) MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem 286: 420-428.
52. Jin Y, Wang C, Liu X, Mu W, Chen Z, et al. (2011) Molecular Characterization of the MicroRNA-138-Fos-like Antigen 1 (FOSL1) Regulatory Module in Squamous Cell Carcinoma. J Biol Chem 286: 40104-40109.
53. Rapley EA, Turnbull C, Al Olama AA, Dermitzakis ET, Linger R, et al. (2009) A genome-wide association study of testicular germ cell tumor. Nat Genet 41: 807-810.
54. Turnbull C, Rapley EA, Seal S, Pernet D, Renwick A, et al. (2010) Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet 42: 604-607.
55. Youn A, Simon R, (2011) Identifying cancer driver genes in tumor genome sequencing studies. Bioinformatics 27: 175-181.
56. Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, et al. (2011) Initial genome sequencing and analysis of multiple myeloma. Nature 471: 467-472.
57. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, et al. (2005) A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
58. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT, (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
59. Lewis-Tuffin LJ, Rodriguez F, Giannini C, Scheithauer B, Necela BM, et al. (2010) Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype. PLoS One 5: e13665.
60. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R, (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A 105: 1608-1613.
61. Greenberg E, Rechavi G, Amariglio N, Solomon O, Schachter J, et al. (2011) Mutagen-specific mutation signature determines global microRNA binding. PLoS One 6: e27400.
62. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, et al. (2009) The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11: 1487-1495.
63. Yantiss RK, Goodarzi M, Zhou XK, Rennert H, Pirog EC, et al. (2009) Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Am J Surg Pathol 33: 572-582.
64. Lytle JR, Yario TA, Steitz JA, (2007) Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR. Proc Natl Acad Sci U S A 104: 9667-9672.
65. Schnall-Levin M, Zhao Y, Perrimon N, Berger B, (2010) Conserved microRNA targeting in Drosophila is as widespread in coding regions as in 3′UTRs. Proc Natl Acad Sci U S A 107: 15751-15756.
66. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, et al. (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 39: D945-950.
67. Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, et al. (2004) The UCSC Table Browser data retrieval tool. Nucleic Acids Res 32: D493-496.
68. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, et al. (2011) The UCSC Genome Browser database: update 2011. Nucleic Acids Res 39: D876-882.
69. Blankenberg D, Von Kuster G, Coraor N, Ananda G, Lazarus R, et al. (2010) Galaxy: a web-based genome analysis tool for experimentalists. Curr Protoc Mol Biol Chapter 19: Unit 19 10 11-21.
70. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
71. Mailman MD, Feolo M, Jin Y, Kimura M, Tryka K, et al. (2007) The NCBI dbGaP database of genotypes and phenotypes. Nat Genet 39: 1181-1186.
72. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362-9367.
73. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, et al. (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29: 308-311.
74. Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, et al. (2011) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 39: D38-51.
75. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
76. Chen ZJ, Zhao H, He L, Shi Y, Qin Y, et al. (2011) Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 43: 55-59.
77. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, et al. (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24: 2938-2939.
78. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, et al. (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A 103: 9136-9141.
79. Jiang J, Lee EJ, Gusev Y, Schmittgen TD, (2005) Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res 33: 5394-5403.
80. Jukic DM, Rao UN, Kelly L, Skaf JS, Drogowski LM, et al. (2010) Microrna profiling analysis of differences between the melanoma of young adults and older adults. J Transl Med 8: 27.
81. Guo C, Sah JF, Beard L, Willson JK, Markowitz SD, et al. (2008) The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 47: 939-946.
82. Feng N, Xu B, Tao J, Li P, Cheng G, et al. (2012) A miR-125b binding site polymorphism in bone morphogenetic protein membrane receptor type IB gene and prostate cancer risk in China. Mol Biol Rep 39: 369-373.
83. D'Alessandro V, Muscarella LA, Copetti M, Zelante L, Carella M, et al. (2008) Molecular detection of neuron-specific ELAV-like-positive cells in the peripheral blood of patients with small-cell lung cancer. Cell Oncol 30: 291-297.
84. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
85. Zeng J, Ge Z, Wang L, Li Q, Wang N, et al. (2010) The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells. Gastroenterology 138: 981-992.
86. Chakravarti N, Lotan R, Diwan AH, Warneke CL, Johnson MM, et al. (2007) Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis. Clin Cancer Res 13: 4817-4824.
87. Schotte D, Chau JC, Sylvester G, Liu G, Chen C, et al. (2009) Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia 23: 313-322.
88. Leidinger P, Keller A, Borries A, Reichrath J, Rass K, et al. (2010) High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer 10: 262.
89. Siva K, Venu P, Mahadevan A, Shankar SK, Inamdar MS, (2007) Human BCAS3 expression in embryonic stem cells and vascular precursors suggests a role in human embryogenesis and tumor angiogenesis. PLoS One 2: e1202.
90. Gururaj AE, Singh RR, Rayala SK, Holm C, den Hollander P, et al. (2006) MTA1, a transcriptional activator of breast cancer amplified sequence 3. Proc Natl Acad Sci U S A 103: 6670-6675.
91. Yamamoto M, Cid E, Bru S, Yamamoto F, (2011) Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers. PLoS One 6: e17149.